MedPath

Evaluation of Effectiveness of vitamin D on immunity of atopic dermatitis patients

Phase 3
Conditions
Atopic dermatitis.
Other atopic dermatitis
Registration Number
IRCT20150716023235N13
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Patients up to 50 years old who have clinical signs of atopic dermatitis
Low serum vitamin D levels
No oral drug for controlling atopic dermatitis recently

Exclusion Criteria

Patients with other atopic diseases
Having skin infections

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical symptoms of atopic dermatitis. Timepoint: At the beginning of the study (before the intervention) and 2 months after the start of the consumption. Method of measurement: SCORAD questionnaire.;Frequency of T reg cells in the blood. Timepoint: At the beginning of the study (before the intervention) and 2 months after the start of the consumption. Method of measurement: Flowcytometry.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath